Novo Nordisk has said it will move to a unified list price of $675 across Ozempic, Wegovy, and Rybelsus beginning January 1, 2027, which could shift employer math again
Meet the experts : Alexandra Sowa, MD, is an internal medicine doctor specializing in preventative health, nutrition, and obesity medicine and the author of the forthcoming book The Ozempic Revolution
R.ThomasR.OSullivanB
In recent years, several antagonists targeting STING palmitoylation have been developed to attenuate STING-mediated inflammation, such as C-170, H-151, nitrofatty acids (NO2-FAs), BPK-21, and 4-octyl itaconate, which block STING palmitoylation through covalent modification of Cys88/91 of SIING and inhibit its downstream type I interferon signaling (103105)
2026 regulatory note: Compounded GLP-1 medications are not FDA-approved finished drug products